Get all your news in one place.
100's of premium titles.
One app.
Start reading
AAP
AAP
Business
Derek Rose

FOUND: Aussie imaging agent to help brain cancer patients - What They Never Told You

Telix Pharmaceutical's imaging agent Pixclara is hoped to help better treatment of brain cancers. (AAP PHOTOS)

US regulators have approved a Melbourne biotech company's imaging agent that should help doctors determine whether a patient's brain cancer is being treated successfully.

The US Food and Drug Administration over the weekend approved Telix Pharmaceutical's Pixclara, a radioactive intravenous infusion that binds to brain cancer cells so they are highlighted on PET scans.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.